Carotid body chemosensitivity: early biomarker of dysmetabolism in humans.
João P Cunha-GuimaraesMaria P GuarinoAna T TimóteoIolanda CairesJoana F SacramentoMaria J RibeiroMafalda SelasJoão C P SantiagoMiguel Mota-CarmoSilvia V CondePublished in: European journal of endocrinology (2020)
We conclude that CB is overactive in prediabetes subjects and that peripheral chemosensitivity correlates with fasting insulin and insulin resistance representing a novel non-invasive functional biomarker to forecast early metabolic disease.